Latest filing published 06 Feb 2026 for 프리시젼바이오.
황규연: trading record in brief
황규연 discloses dealings in 프리시젼바이오 to DART (FSS). Between 18 March 2022 and 6 February 2026, the trades on record add up to 2 filings.
Every open-market trade on record is a purchase: 2 purchases worth €72k, and no sale. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 1 purchase and no sales.
The record was last updated on 6 February 2026 with an open-market purchase in 프리시젼바이오. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 황규연
Open company profiles for insider transactions, fundamentals and analyst consensus when available.